Sibirin Flunarizine Hydrochloride Capsules, or Flunarizine Hydrochloride Capsules, Nimodipine and Flunarizine Hydrochloride Capsules can be taken together and should be used in accordance with medical advice. Nimodipine is a channel blocker, can inhibit smooth muscle contraction, relieve vasospasm, dilate cerebral blood vessels. It can be used for cerebral vasospasm (after subarachnoid space hemorrhage), improve blood circulation during the recovery period of acute cerebrovascular disease. Nimodipine adverse reactions are decreased blood pressure, hepatitis, skin tingling, gastrointestinal bleeding, thrombocytopenia. The contraindications of this product are not clear, cerebral edema, increased intracranial pressure, hepatic function impairment should be used with caution. Flunarizine Hydrochloride Capsules is a selective calcium antagonist, which can improve cerebral microcirculation and neuronal metabolism, inhibit platelet coagulation, cerebral vasospasm and so on. It can be used for the prophylactic treatment of migraine and symptomatic treatment of vertigo caused by vestibular dysfunction. Adverse reactions of Flunarizine Hydrochloride Capsules include infection, rhinitis, increased appetite, depression, somnolence, constipation, myalgia, menstrual disorders, breast pain and so on. This product is contraindicated in people with Parkinson’s disease, history of depression, other extrapyramidal disorders. Flunarizine hydrochloride capsules and nimodipine instructions do not point out that the two will occur drug interactions, there is no contraindication to pairing, can be taken together, should be standardized under the guidance of a doctor.
Support Us
Discussion
Share your experience, or seek help from fellow patients.
